Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Triggering endogenous immunosuppressive mechanisms by combined targeting of Dipeptidyl peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/ CD13)--a novel approach for the treatment of inflammatory bowel disease.
Bank U, Heimburg A, Helmuth M, Stefin S, Lendeckel U, Reinhold D, Faust J, Fuchs P, Sens B, Neubert K, Täger M, Ansorge S. Bank U, et al. Among authors: tager m. Int Immunopharmacol. 2006 Dec 20;6(13-14):1925-34. doi: 10.1016/j.intimp.2006.09.014. Epub 2006 Oct 17. Int Immunopharmacol. 2006. PMID: 17161345
Novel aspects of cellular action of dipeptidyl peptidase IV/CD26.
Ansorge S, Nordhoff K, Bank U, Heimburg A, Julius H, Breyer D, Thielitz A, Reinhold D, Täger M. Ansorge S, et al. Among authors: tager m. Biol Chem. 2011 Mar;392(3):153-68. doi: 10.1515/BC.2011.008. Biol Chem. 2011. PMID: 21194362
97 results